Skip to main content
Humanitarian biotech · Based in Germany

Coordinating life‑saving treatment so no child with a rare disease is left untreated.

Neuravex connects families, doctors, hospitals, pharma companies and global donors to unlock life‑saving therapies for children with rare diseases, beginning with spinal muscular atrophy (SMA).

Starting with one verified child, scaling case by case.
Germany ↔ India coordination

Compassion, transparency, measurable impact. Neuravex is not a fundraising campaign — it is a coordinated system for rare‑disease access.

How Neuravex operates

From verified case to coordinated treatment pathway

We combine clinical review, hospital coordination, pharma engagement and fundraising strategy into one transparent process — designed so that families, doctors and donors can collaborate effectively.

Step 01
Verify diagnosis & urgency

Review genetic reports, clinical notes and current treatment, confirm rare‑disease subtype, and assess time‑critical interventions with our medical advisors.

Medical rigor
Step 02
Connect to expert doctors & hospitals

Link the family’s treating physician with German or international experts and identify hospitals able to deliver advanced therapies in the child’s country.

Clinical network
Step 03
Open pharma & donor pathways

Engage pharma compassionate‑use and access programs where available, and design a funding plan bridging institutional donors, CSR and public crowdfunding.

Access & funding
Step 04
Track outcomes & publish impact

Monitor treatment milestones with the care team, document fund flows, and publish anonymized outcomes so the global community can see real impact per child.

Transparency

Who we serve

Families, clinicians, hospitals, donors and pharma — working as one team

Neuravex is designed to be a neutral, trusted coordination layer between all stakeholders involved in rare‑disease care.

For families

Guidance in a complex, global system

We help families navigate diagnosis, treatment options and funding without replacing their treating doctor.

  • Case review and explanation in clear language.
  • Connection to specialists for second opinions.
  • Structured plan for hospital admission and timelines.
  • Support to build or optimize fundraising campaigns.
For doctors & hospitals

A structured partner, not noise

We minimize chaos by curating documentation, aligning expectations and coordinating with donors and pharma.

  • Standardized case summaries and documentation packs.
  • Secure channel for expert‑to‑expert discussions.
  • Support engaging hospital boards on pro‑bono or reduced‑cost slots.
  • Outcome tracking that respects clinical workflows.
For donors & pharma

Verified impact with clear traceability

We are building a rare‑disease impact pipeline where every contribution is linked to a specific child and outcome.

  • Case‑level visibility on medical plans and funding gaps.
  • Preference for direct payments to hospitals or authorized partners.
  • Ethical collaboration with pharma compassionate‑use and access programs.
  • Aggregated, anonymized data on outcomes to inform future policy.

Our foundation

Compassion, transparency, trust and measurable impact

Neuravex is built to be the first trusted name families think of when a child in India — or anywhere in the world — is diagnosed with a rare disease.

  • Compassion with clinical discipline

    Every case is a human story, but we insist on rigorous medical verification and realistic treatment plans.

  • Radical transparency

    Our aim is clear documentation of decisions, fund flows and outcomes; where possible, donations flow directly to hospitals or authorized providers — not individuals.

  • Professional credibility

    We are building a network of clinicians, scientists and advisors in Germany and globally to ensure medical decisions meet international standards.

Current focus
SMA and ultra‑rare pediatric diseases

Starting with spinal muscular atrophy and expanding as our expert and donor network grows.

Pilot phase
Case‑by‑case

We intentionally start small: a handful of deeply supported children to prove the model before scaling.

Long‑term vision
Global rare‑disease access layer

When a child is diagnosed anywhere, “Contact Neuravex” should be one of the first responses.

Start with one child

Refer a child or explore partnership

Share a case or reach out as a clinician, hospital, donor or pharma partner. We will review each message individually and respond with next steps.

Note This form is for initial contact only. In medical emergencies, please contact local emergency services.

We use this only to contact you about your message.

This form does not replace emergency medical care. By submitting, you agree that Neuravex may review this information and contact you about potential next steps.